Oleastro Mónica, Coelho Marta, Gião Marília, Coutinho Salomé, Mota Sandra, Santos Andrea, Rodrigues João, Faria Domitília
National Reference Laboratory for Gastrointestinal Infections, Department of Infectious Diseases, National Institute of Health Dr, Ricardo Jorge, Av, Padre Cruz, 1649-016 Lisbon, Portugal.
BMC Infect Dis. 2014 Apr 17;14:209. doi: 10.1186/1471-2334-14-209.
Clostridium difficile infection (CDI) is the leading cause of healthcare-associated diarrhea, and several outbreaks with increased severity and mortality have been reported. In this study we report a C. difficile PCR ribotype 027 outbreak in Portugal, aiming to contribute to a better knowledge of the epidemiology of this agent in Europe.
Outbreak report with retrospective study of medical records and active surveillance data of all inpatients with the diagnosis of CDI, from 1st January to 31th December 2012, in a Portuguese hospital. C. difficile isolates were characterized regarding ribotype, toxin genes and moxifloxin resistance. Outbreak control measures were taken, concerning communication, education, reinforcement of infection control measures, optimization of diagnosis and treatment of CDI, and antibiotic stewardship.
Fifty-three inpatients met the case definition of C. difficile-associated infection: 55% males, median age was 78.0 years (interquartile range: 71.0-86.0), 75% had co-morbidities, only 15% had a nonfatal condition, 68% had at least one criteria of severe disease at diagnosis, 89% received prior antibiotherapy, 79% of episodes were nosocomial. CDI rate peak was 13.89/10,000 bed days. Crude mortality rate at 6 months was 64.2% while CDI attributable cause was 11.3%. Worse outcome was related to older age (P = 0.022), severity criteria at diagnosis (leukocytosis (P = 0.008) and renal failure), and presence of fatal underlying condition (P = 0.025). PCR ribotype 027 was identified in 16 of 22 studied samples.
This is the first report of a 027-CDI outbreak in Portugal. We emphasize the relevance of the measures taken to control the outbreak and highlight the importance of implementing a close and active surveillance of CDI.
艰难梭菌感染(CDI)是医疗保健相关腹泻的主要原因,并且已有多起严重性和死亡率增加的暴发报告。在本研究中,我们报告了葡萄牙的一次艰难梭菌PCR核糖型027暴发,旨在促进对该病原体在欧洲流行病学的更好了解。
对一家葡萄牙医院2012年1月1日至12月31日期间所有诊断为CDI的住院患者的病历进行回顾性研究,并结合主动监测数据进行暴发报告。对艰难梭菌分离株进行核糖型、毒素基因和莫西沙星耐药性特征分析。采取了暴发控制措施,包括沟通、教育、加强感染控制措施、优化CDI的诊断和治疗以及抗生素管理。
53名住院患者符合艰难梭菌相关感染的病例定义:男性占55%,中位年龄为78.0岁(四分位间距:71.0 - 86.0),75%有合并症,仅15%病情不致命,68%在诊断时有至少一项严重疾病标准,89%接受过先前的抗生素治疗,79%的感染事件为医院感染。CDI发病率峰值为13.89/10000床日。6个月时的粗死亡率为64.2%,而CDI归因原因死亡率为11.3%。较差的预后与年龄较大(P = 0.022)、诊断时的严重程度标准(白细胞增多(P = 0.008)和肾衰竭)以及存在致命的基础疾病(P = 0.025)有关。在22个研究样本中的16个中鉴定出PCR核糖型027。
这是葡萄牙027型CDI暴发的首次报告。我们强调了为控制暴发所采取措施的相关性,并突出了对CDI实施密切主动监测的重要性。